Topiramate treatment is neuroprotective and reduces oligodendrocyte loss after cervical spinal cord injury.
Excess glutamate release and associated neurotoxicity contributes to cell death after spinal cord injury (SCI). Indeed, delayed administration of glutamate receptor antagonists after SCI in rodents improves tissue sparing and functional recovery. Despite their therapeutic potential, most glutamate r...
Main Authors: | John C Gensel, C Amy Tovar, Jacqueline C Bresnahan, Micheal S Beattie |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3302770?pdf=render |
Similar Items
-
Topiramate as a neuroprotective agent in a rat model of spinal cord injury
by: Firat Narin, et al.
Published: (2017-01-01) -
Pharmacological neuroprotection in cervical spinal cord injury
by: Lee, Jae Ho
Published: (2010) -
Pharmacological neuroprotection in cervical spinal cord injury
by: Lee, Jae Ho
Published: (2010) -
Pharmacological neuroprotection in cervical spinal cord injury
by: Lee, Jae Ho
Published: (2010) -
Continued development of azithromycin as a neuroprotective therapeutic for the treatment of spinal cord injury and other neurological conditions
by: Timothy J Kopper, et al.
Published: (2021-01-01)